Notwithstanding the provisions of section 21a-106 concerning misbranding of drugs or devices, a drug shall not be considered misbranded when repackaged by a pharmacy or an institutional pharmacy into stock packages for use within the pharmacy or the institutional pharmacy, provided the stock packages contain a label indicating the drug's name, strength, lot number, manufacturer and expiration date, if any.
Conn. Gen. Stat. § 20-618
(Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when
Known as the Pharmacy Practice Act
The act spans §§ 20–20 (94 sections).
(P.A. 79-116, S. 2; P.A. 95-264, S. 39.) History: Sec. 19-226a transferred to Sec. 21a-107 in 1983; P.A. 95-264 made technical changes; Sec. 21a-107 transferred to Sec. 20-618 i…
Official source: Connecticut General Assembly. Reproduced from public-domain Connecticut statutes; confirm against the official source for the current text. Not legal advice.